115 related articles for article (PubMed ID: 7511488)
1. Excretion of 3,6-epoxydicarboxylic acids in peroxisomal disorders.
Pitt JJ; Poulos A
Clin Chim Acta; 1993 Dec; 223(1-2):23-9. PubMed ID: 7511488
[TBL] [Abstract][Full Text] [Related]
2. Characteristic urine organic acid profile in peroxisomal biogenesis disorders.
Korman SH; Mandel H; Gutman A
J Inherit Metab Dis; 2000 Jun; 23(4):425-8. PubMed ID: 10896310
[No Abstract] [Full Text] [Related]
3. Mass spectrometric identification of 2-hydroxy-sebacic acid in the urines of patients with neonatal adrenoleukodystrophy and Zellweger syndrome.
Rocchiccioli F; Cartier PH; Aubourg P; Bougnères PF
Biomed Environ Mass Spectrom; 1986 Jun; 13(6):315-8. PubMed ID: 2943344
[TBL] [Abstract][Full Text] [Related]
4. Urinary dicarboxylic acids in X-linked adrenoleukodystrophy.
Kodama S; Nishio H; Nakajima T; Nakamura H
Acta Paediatr Jpn; 1990 Jun; 32(3):257-61. PubMed ID: 2239298
[TBL] [Abstract][Full Text] [Related]
5. Medium- and long-chain dicarboxylic aciduria in patients with Zellweger syndrome and neonatal adrenoleukodystrophy.
Rocchiccioli F; Aubourg P; Bougnères PF
Pediatr Res; 1986 Jan; 20(1):62-6. PubMed ID: 3945517
[TBL] [Abstract][Full Text] [Related]
6. Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.
Mayatepek E; Lehmann WD; Fauler J; Tsikas D; Frölich JC; Schutgens RB; Wanders RJ; Keppler D
J Clin Invest; 1993 Mar; 91(3):881-8. PubMed ID: 8450067
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous enantioselective analysis of chiral urinary metabolites in patients with Zellweger syndrome.
Muth A; Jung J; Bilke S; Scharrer A; Mosandl A; Sewell AC; Böhles H
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 792(2):269-77. PubMed ID: 12860034
[TBL] [Abstract][Full Text] [Related]
8. Stable isotope dilution analysis of very long chain fatty acids in plasma, urine and amniotic fluid by electron capture negative ion mass fragmentography.
Stellaard F; ten Brink HJ; Kok RM; van den Heuvel L; Jakobs C
Clin Chim Acta; 1990 Nov; 192(2):133-44. PubMed ID: 1705871
[TBL] [Abstract][Full Text] [Related]
9. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
Molzer B; Stöckler S; Bernheimer H
Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
[TBL] [Abstract][Full Text] [Related]
10. Complementation analysis of peroxisomal disorders and classical Refsum.
Poll-The BT; Skjeldal OH; Stokke O; Demaugre F; Saudubray JM
Prog Clin Biol Res; 1990; 321():537-43. PubMed ID: 1691507
[No Abstract] [Full Text] [Related]
11. Non-ketotic C6-C10-dicarboxylic aciduria: biochemical investigations of two cases.
Gregersen N; Rosleff F; Kølvraa S; Hobolth N; Rasmussen K; Lauritzen R
Clin Chim Acta; 1980 Mar; 102(2-3):179-89. PubMed ID: 6892795
[TBL] [Abstract][Full Text] [Related]
12. Urinary organic acids in peroxisomal disorders: a simple screening method.
Yamaguchi S; Iga M; Kimura M; Suzuki Y; Shimozawa N; Fukao T; Kondo N; Tazawa Y; Orii T
J Chromatogr B Biomed Sci Appl; 2001 Jul; 758(1):81-6. PubMed ID: 11482738
[TBL] [Abstract][Full Text] [Related]
13. [Peroxisomes and peroxisomal diseases].
Petelenz M; Gonciarz Z; Grzybek H; Panz B
Postepy Hig Med Dosw; 1991; 45(1-2):77-99. PubMed ID: 1717967
[TBL] [Abstract][Full Text] [Related]
14. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
[TBL] [Abstract][Full Text] [Related]
15. Bile acids in peroxisomal disorders.
Van Eldere JR; Parmentier GG; Eyssen HJ; Wanders RJ; Schutgens RB; Vamecq J; Van Hoof F; Poll-The BT; Saudubray JM
Eur J Clin Invest; 1987 Oct; 17(5):386-90. PubMed ID: 2446876
[TBL] [Abstract][Full Text] [Related]
16. B vitamin supplementation reduces excretion of urinary dicarboxylic acids in autistic children.
Kałużna-Czaplińska J; Socha E; Rynkowski J
Nutr Res; 2011 Jul; 31(7):497-502. PubMed ID: 21840465
[TBL] [Abstract][Full Text] [Related]
17. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients.
Roscher AA; Hoefler S; Hoefler G; Paschke E; Paltauf F; Moser A; Moser H
Pediatr Res; 1989 Jul; 26(1):67-72. PubMed ID: 2475849
[TBL] [Abstract][Full Text] [Related]
18. Increased urinary excretion of dicarboxylic acids and 4-hydroxyphenyllactic acid in patients with Zellweger syndrome.
Mayatepek E; Seppel CK; Hoffmann GF
Eur J Pediatr; 1995 Sep; 154(9):755-6. PubMed ID: 8582432
[No Abstract] [Full Text] [Related]
19. Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.
Hall NA; Lynes GW; Hjelm NM
Clin Chem; 1988 Jun; 34(6):1041-5. PubMed ID: 2454167
[TBL] [Abstract][Full Text] [Related]
20. Peroxisomal disorders: clinical commentary and future prospects.
Wilson GN; Holmes RD; Hajra AK
Am J Med Genet; 1988 Jul; 30(3):771-92. PubMed ID: 2461077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
